Gene · 5420
Papers2,215
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,215
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Urinary podocalyxin identifies a pre-albuminuric kidney injury window and stratifies 12-year diabetic kidney disease risk in youth with type 1 diabetes mellitus. | Pediatr Nephrol | 2026 | 42104992 | PubTator, text mining | PubMed |
| Single-cell profiling uncovers a hypoxia-vascular-immune axis underlying poor immunotherapy response in acral versus cutaneous melanoma. | J Transl Med | 2026 | 42098765 | PubTator, text mining | PubMed |
| Corrigendum to "Failure of podocalyxin suppression and HOXA10/HOXA11 activation characterizes endometrial dysfunction in hyperandrogenic PCOS" [Mol. Cell. Endocrinol 616 (2026) 112763]. | Mol Cell Endocrinol | 2026 | 42020296 | PubTator, text mining | PubMed |
| Dysregulated endometrial podocalyxin and LIF expression in women with ovarian endometrioma. | Gynecol Endocrinol | 2026 | 42015488 | PubTator, text mining | PubMed |
| Neurochondrin drives colorectal cancer progression by modulating the PODXL-Ezrin axis and mitochondrial function. | Cell Death Dis | 2026 | 41997895 | PubTator, text mining | PubMed |
| Differential regulation of endometrial receptivity markers by levonorgestrel-releasing and copper intrauterine devices: A cross-sectional study. | J Gynecol Obstet Hum Reprod | 2026 | 41921785 | PubTator, text mining | PubMed |
| Dynamics and Predictive Values of Urinary Podocyte Biomarkers Following SGLT2 Inhibition in CKD. | Life (Basel) | 2026 | 41901047 | PubTator, text mining | PubMed |
| Urinary biomarkers and serum VEGF in preterm infants with retinopathy of prematurity treated with ranibizumab. | Pediatr Int | 2026 | 41852194 | PubTator, text mining | PubMed |
| A comprehensive genome-wide scan for parent-of-origin expressed genes in the pig clarifies the conservation landscape of genomic imprinting. | Genet Sel Evol | 2026 | 41803684 | PubTator, text mining | PubMed |
| PINCH proteins orchestrate vascular mural cell homeostasis through integrated signaling and transcriptional networks. | Angiogenesis | 2026 | 41795751 | PubTator, text mining | PubMed |
| Molecular mechanisms in podocytopathies: finding suitable targets for a new era of glomerular gene therapy. | Clin Kidney J | 2026 | 41788620 | PubTator, text mining | PubMed |
| Distinct Proteomic Signatures Driving Progression of Sarcopenia: A Longitudinal Multicohort Study. | J Cachexia Sarcopenia Muscle | 2026 | 41782349 | PubTator, text mining | PubMed |
| Topological Data Analysis for Unsupervised Feature Selection in Large Scale Spatial Omics Data Sets. | Bull Math Biol | 2026 | 41779089 | PubTator, text mining | PubMed |
| Diagnostic performance of urinary podocyte biomarkers and TGF-β/Smad signaling markers in diabetic nephropathy. | J Diabetes Metab Disord | 2026 | 41767439 | PubTator, text mining | PubMed |
| Back to the Future-A 50-Year Dive into Embryo Implantation Research: Cell Biological Paradox, Epithelial Cell Polarity, and EMT. | Biomolecules | 2026 | 41750362 | PubTator, text mining | PubMed |
| Therapeutic potential of TMSC-Exo for non-alcoholic fatty liver disease using the liver-on-a-chip model. | J Transl Int Med | 2026 | 41727958 | PubTator, text mining | PubMed |
| Vitamin D Reprograms Non-Coding RNA Networks to Block Zika Virus in Human Macrophages. | Pathophysiology | 2026 | 41718393 | PubTator, text mining | PubMed |
| Structural and Dynamic Insights into Podocalyxin-Ezrin Interaction as a Target in Cancer Progression. | J Xenobiot | 2026 | 41718268 | PubTator, text mining | PubMed |
| Failure of podocalyxin suppression and HOXA10/HOXA11 activation characterizes endometrial dysfunction in hyperandrogenic PCOS. | Mol Cell Endocrinol | 2026 | 41713640 | PubTator, text mining | PubMed |
| Can Podocalyxin Immunoreactivity Facilitate Histopathological Diagnosis of Placenta Accreta Spectrum (PAS) Disorders? | J Obstet Gynaecol Res | 2026 | 41702842 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5420/papers?page=2